ACE-031

Peptide

ACE-031 is retained as a catalog identity with independently verified primary-literature context. No qualified exposure model, dose recommendation, efficacy claim, or safety claim is provided.

Pharmacokinetic model

A route-level PK model for ace-031 is being prepared from published data. Dosing references, studies, and documented interactions are below; the app catalog is updated as models are validated.

Key facts

Category
Peptide
Suggested cadence
once daily

Research behind this entry

  1. A single ascending-dose study of muscle regulator ACE-031 in healthy volunteers. Attie KM, Borgstein NG, Yang Y, Condon CH, Wilson DM, Pearsall AE, Kumar R, Willins DA, Seehra JS, Sherman ML · Muscle & nerve, 2013 DOI

    This citation reports a human clinical study involving ACE-031. It does not establish a qualified human dose, safety profile, efficacy claim, or pharmacokinetic route for this catalog record.

1 published study referenced in the app, each with a plain-language summary.